A detailed history of Phoenix Holdings Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 13,920 shares of NVO stock, worth $1.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,920
Previous 14,622 4.8%
Holding current value
$1.48 Million
Previous $2.09 Million 20.6%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.07 - $145.42 $83,587 - $102,084
-702 Reduced 4.8%
13,920 $1.66 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $1.79 Million - $2.15 Million
14,622 New
14,622 $2.09 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $37,569 - $45,132
428 Added 7.44%
6,182 $639,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $523,268 - $1.15 Million
5,754 New
5,754 $523,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $344,084 - $413,763
2,600 New
2,600 $413,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.